Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.

Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q44826211

about

Genetic susceptibility in childhood acute leukaemias: a systematic review Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia ABCB1 genetic variants in leukemias: current insights into treatment outcomes Mathematical Simulation of Transport Kinetics of Tumor-Imaging Radiopharmaceutical 99mTc-MIBI Genetic susceptibility to childhood leukaemia Effect of ABCB1 polymorphism on the clinical outcome of osteosarcoma patients after receiving chemotherapy ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.Imaging of multidrug resistance in cancer ABCG2: a perspective.Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer.Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene ABCB1 polymorphism and susceptibility to acute lymphoblastic leukemia: a meta analysis.Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia.Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy.ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia The association between polymorphisms in the MDR1 gene and risk of cancer: a systematic review and pooled analysis of 52 case-control studies.ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.Pharmacogenetics of acute lymphoblastic leukemia treatment response.Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima.Genetic Polymorphisms Associated to Folate Transport as Predictors of Increased Risk for Acute Lymphoblastic Leukemia in Mexican Children.Association of MDR1 gene polymorphisms with the risk of hepatocellular carcinoma in the Chinese Han population Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia.ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib.Pharmacogenomics of pediatric acute lymphoblastic leukemia.Drug transporter pharmacogenetics in nucleoside-based therapies.Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.The controversial role of ABC transporters in clinical oncology.ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies.Association between the MDR1 gene variant C3435T and risk of leukaemia: a meta-analysis.Pharmacogenetics of childhood acute lymphoblastic leukemia.Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.

P2860

Q28081832-8DFBDF28-846B-4DCB-8F63-2327137229D7 Q28245060-C632F80D-C558-4BE5-A555-C58ECFA3A995 Q28943431-C48887D6-6DC7-49CD-91C2-469097430F3F Q33707782-3FEBC5A4-BDE0-4B56-B72A-3B6B9AE4173F Q33862496-9E5838A2-FF11-4C10-80CA-9D32A20335A6 Q33887427-48092F6B-0FCE-4311-9D14-48D445A5CAB8 Q34002029-0F2C3FCA-2D2F-4836-A2E5-349AB3FC6515 Q34084892-C9A6E1F1-E4E1-4B27-8176-6A2CA645A66E Q34187283-0796E7F8-1BDD-44D7-B458-4F13237D841E Q34823564-6EDDA578-DDE4-4EA8-81B7-07F465DD2318 Q35016817-60B14064-092E-44B1-B146-D7098054C0C4 Q35071734-630F1BC9-AA37-4558-900B-FD7C972B535E Q35158345-CFCF7EAA-E35B-4F66-9058-97C28411D8D3 Q35593505-DEBA4AC0-2C3E-4793-BEEF-1BC0174CB0AB Q35809516-0A3BACC7-8C50-4301-B247-FD530EBF2EE9 Q35870856-A3DA1A37-6964-42AE-B5CA-96E0E7A968D1 Q35915497-C97D85E5-9675-403C-BAC6-FAC1BD42362A Q36120816-379E6DE4-5864-40CD-A33B-66269FBF82DD Q36204229-0FE878BA-46C1-4894-859C-7B5D4AF21155 Q36286302-8FA964D5-6478-402F-B775-3F9D1134D06E Q36579071-435718FF-972E-42AF-A238-828713F52ED6 Q36592129-F29A6278-2FF1-431D-A8F1-5CBB4C0955F5 Q36605135-B69D7DDB-CC2C-4482-BE9C-59E7C692BA2F Q36891521-A3ABCA51-4202-480E-8BAE-23108ADEE68B Q36893545-78E33870-3CE2-488F-861B-C11BFFEF7F4A Q36968156-73635923-86E6-463F-B535-CA1C34A12319 Q37066299-86743491-5B92-402B-B629-8CB3A6EBE6D2 Q37153683-773604AD-48A3-4D17-BFB1-98BD564D620A Q37371415-3171517C-5A93-4690-8238-041D68C92F3F Q37650740-F507F466-9C5A-40EB-B3DC-32CD440E3D25 Q37652283-FF5EEE5C-2E9A-47FC-B821-C7D34B0BF186 Q37739432-7F800C8C-B0E7-440B-9AB5-D4A37D0E5FBE Q37760954-DDAD659F-1C5D-4493-92E6-62FD53F7AC49 Q37761616-B1C9958D-7A1D-4DBC-8DD9-110F1B7117E4 Q37941758-216CE522-1BE8-4DAE-997C-7B96FD346C4D Q38070911-0E84C6E6-25DC-46A0-8857-6D4208C8E6A9 Q38111448-A333D3D2-37BA-4B5E-94ED-A96B1A4ED3B5 Q38243175-5AE4D4E4-0764-4126-93CD-EA2C07A4B46B Q38686308-65980E83-EDC0-4523-B563-E4A0A09EB2A3 Q38888350-6EA21CE3-27B3-4176-8C03-4162D1ACEAB7

P2860

Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q44826211

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Functional C3435T polymorphism ...... acute lymphoblastic leukemia.

@en

Functional C3435T polymorphism ...... acute lymphoblastic leukemia.

@nl

type

label

Functional C3435T polymorphism ...... acute lymphoblastic leukemia.

@en

Functional C3435T polymorphism ...... acute lymphoblastic leukemia.

@nl

prefLabel

Functional C3435T polymorphism ...... acute lymphoblastic leukemia.

@en

Functional C3435T polymorphism ...... acute lymphoblastic leukemia.

@nl

P1433

Q44826211-5AE53D40-D421-4F1A-9017-E29B3D18DBDD

P1476

Q44826211-2108D95E-7EBD-4144-B655-14CD821E5EF7

P2093

Q44826211-75493AC3-C722-4534-AE59-0D4CCD138906

Q44826211-7DEFF309-07FB-4F53-8060-539C2F63E50B

Q44826211-8710960F-F328-4DE9-8A78-36B359A112A1

Q44826211-9F6ECB85-39FD-4681-A189-7B691CB3C656

Q44826211-BBFF7ECA-DCCC-449E-847B-8186F5345501

Q44826211-D619532F-7033-49D6-B9F3-3721B7BA4BA3

P2860

Q44826211-03FE224C-890F-4AE4-8414-A3DDC5AF37EF

Q44826211-0AF48593-E81E-463F-85A2-772290E0C7C3

Q44826211-1B10C296-4078-46B7-A6D3-23812DBD43C2

Q44826211-1F4BA8C8-ECC7-49EF-AFE9-F7A141AB8B22

Q44826211-31B76C89-83E5-48E4-83D5-6AD26418E004

Q44826211-3CA483AC-F10A-4826-B7B7-C44F4E6EA6C1

Q44826211-46CF4775-1201-4986-80FA-F660149E029B

Q44826211-51868E5F-D397-4C6D-89EF-8CB12EA30527

Q44826211-555DF7DB-8175-4933-B757-242FC42435EF

Q44826211-565673F2-FC0F-46F0-893B-9A7816F73DFA

P304

Q44826211-AACED478-5FB0-4A5C-B5A4-4944902C506C

P31

Q44826211-50C6C10B-2C74-4E24-B13A-28092711C8D0

P356

Q44826211-66AFC03A-7007-4A34-BA46-495A51DEBFD1

P433

Q44826211-2CE08BEC-6C67-4E0B-9D61-FD6D763F0714

P478

Q44826211-B22F7CC4-23EC-4B2E-B850-A3FCDC57804B

P50

Q44826211-4AD563F8-B8E4-4F7D-9ACB-5C19013E5910

Q44826211-623CF7BE-63D3-4A94-B6AE-3AA10D55410B

P577

Q44826211-B0719026-6337-4DDA-98BD-84ED6A780175

P698

Q44826211-42A2B19E-4FE6-4AEC-B3F9-0E5881BB981C

P921

Q44826211-7C84C7B9-D4DF-4C59-8930-80967FA33ADB

P356

J.1600-0609.2004.00228.X

P1433

European Journal of Haematology

P1476

Functional C3435T polymorphism ...... d acute lymphoblastic leukemia

@en

P2093

Jerzy Bodalski

http://www.w3.org/2001/XMLSchema#string

Joanna Trelinska

http://www.w3.org/2001/XMLSchema#string

Magda Mistygacz

http://www.w3.org/2001/XMLSchema#string

Marek Mirowski

http://www.w3.org/2001/XMLSchema#string

Tadeusz Robak

http://www.w3.org/2001/XMLSchema#string

Wojciech Młynarski

http://www.w3.org/2001/XMLSchema#string

P2860

Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects

Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.

Frequency of C3435T polymorphism of MDR1 gene in African people.

Identification of functionally variant MDR1 alleles among European Americans and African Americans.

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects.

P304

314-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0609.2004.00228.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Krzysztof Jamroziak

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15059065

http://www.w3.org/2001/XMLSchema#string

P921